Ipamorelin: The Selective Growth Hormone Secretagogue
Ipamorelin is a synthetic pentapeptide (five amino acids: Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that stimulates growth hormone release from the anterior pituitary gland through selective activation of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Among the GH secretagogues, ipamorelin is distinguished by its remarkable selectivity - it releases GH without significantly affecting cortisol, prolactin, or aldosterone levels, making it one of the cleanest secretagogues available for research.
Mechanism of Action
Ipamorelin works by mimicking the action of ghrelin at the GHS-R1a receptor on somatotroph cells in the anterior pituitary. When ipamorelin binds this receptor, it triggers an intracellular calcium signaling cascade that stimulates the release of stored growth hormone into the bloodstream.
What Makes Ipamorelin Selective
Unlike GHRP-6 and GHRP-2, which also activate GHS-R1a but produce broader hormonal effects, ipamorelin's unique amino acid sequence provides:
- No significant cortisol elevation: GHRP-6 and hexarelin can increase cortisol by 30-50% at higher doses; ipamorelin maintains cortisol within baseline ranges
- No prolactin stimulation: Important for avoiding prolactin-related side effects
- No appetite stimulation: Unlike GHRP-6, which strongly activates ghrelin's appetite pathway, ipamorelin causes minimal hunger increase
- Dose-dependent GH release: GH output increases linearly with dose up to a saturation point, without the plateau seen with some other secretagogues[1]
Growth Hormone and Muscle Growth
Growth hormone promotes lean muscle mass through several interconnected pathways:
- IGF-1 production: GH stimulates hepatic production of IGF-1 (insulin-like growth factor-1), which directly activates the PI3K/Akt/mTOR pathway - the master regulator of muscle protein synthesis
- Protein synthesis: GH enhances amino acid transport into muscle cells and increases ribosomal efficiency for protein translation
- Lipolysis: GH stimulates hormone-sensitive lipase, promoting fat breakdown and freeing fatty acids as fuel - effectively improving body composition by increasing lean mass while reducing fat mass
- Satellite cell activation: Through IGF-1 signaling, GH promotes the activation and differentiation of muscle satellite cells, supporting long-term muscle fiber repair and growth
Ipamorelin vs. Other Secretagogues
- Ipamorelin: Selective GH release, no cortisol/prolactin spike, no appetite increase, clean side effect profile
- GHRP-6: Strong GH release + significant appetite stimulation + moderate cortisol increase
- GHRP-2: Strong GH release + moderate appetite + slight cortisol/prolactin increase
- Hexarelin: Strongest GH release but rapid desensitization + cortisol/prolactin effects
Research on Body Composition
Clinical studies on ipamorelin have demonstrated meaningful changes in body composition markers:
- Increased lean body mass in both animal and human models
- Reduced adipose tissue, particularly visceral fat depots
- Improved nitrogen retention - an indicator of anabolic activity
- Enhanced recovery markers following exercise-induced muscle damage
A notable clinical trial in post-surgical patients showed that ipamorelin significantly improved bowel recovery time and overall recovery kinetics, suggesting systemic anabolic and recovery-promoting effects[2].
Stacking with GHRH Analogs
Ipamorelin is frequently combined with GHRH analogs like CJC-1295 (with or without DAC) for synergistic GH release. This combination exploits two complementary pathways:
- CJC-1295 (GHRH analog): stimulates GH synthesis and release via the GHRH receptor, effectively "loading" the pituitary with GH
- Ipamorelin (GHS-R agonist): triggers the release of stored GH via the ghrelin receptor, acting as the "trigger" for secretion
The combination typically produces GH pulses 2-3x larger than either peptide alone, more closely mimicking the body's natural pulsatile GH release pattern.
Research Considerations
Ipamorelin's clean selectivity profile makes it a preferred choice for research protocols where isolating GH effects from confounding cortisol or prolactin changes is important. Its lack of appetite stimulation also makes it suitable for body composition research where dietary control is a variable. Researchers should note that ipamorelin works best when administered in a fasted state and timed to complement the body's natural GH pulses (typically pre-sleep or post-exercise).
